🧬 Engineering a Drug Hunter: From Vet School to Big Pharma | Martin Brenner Rerelease (1/3)

Episode notes

The Biotech Startups Podcast is powered by Excedr—helping life science startups accelerate R&D and commercialization with founder-friendly equipment leasing. Skip the upfront costs, stay lean, and focus on breakthrough science. As a TBSP listener, you can get exclusive perks through Excedr's partner network—special savings, promotions, and more. Explore these offers today: "Making medicines, you can help literally the entire world if you get it right." Jon Chee sits down with Martin Brenner, CEO and CSO of iBio, an AI drug discovery company building immunotherapies for difficult-to-treat cancers. Before biotech leadership, Martin built one of pharma's most unconventional careers—electrical engineer in Stuttgart, vet medicine at LMU Munich, PhD embedded at Eli Lilly, youngest scientist to lead a 20-person team there. Part 1 covers his formative years: the family that shaped him, the vet clinic that changed his path, and the professor who lit the match. Key Topics Covered: Engineering Roots and a Rebellious Phase: How Stuttgart shaped Martin early—and why meeting his wife gave him focus.